首款'女性伟哥'有望在美国上市

Female Viagra nears approval

'女性伟哥'有望上市

The first-ever "female Viagra" came one step closer to coming to market, as an advisory committee to the Food and Drug Administration voted Thursday afternoon to recommend that the FDA approve the drug with conditions. The committee voted 18-6 to recommend that the FDA approve flibanserin, a drug designed to boost the low sexual desire of otherwise healthy women.

首款"女性伟哥"距离上市又近了一步。美国食品药物管理局(FDA)的一个咨询委员会4日下午以18比6的投票结果建议FDA有条件批准氟班色林，这是一种提升身体健康但性欲低下的女性的性欲的药物。

The FDA usually follows the recommendations of its advisory committees, but not always.

通常FDA会采纳咨询委员会的建议，但采纳率也并非100%。

Its decision is expected by the end of the summer.

FDA将在夏季末之前做出决定。

The agency has already rejected the drug twice, saying the potential side effects of fainting, nausea, dizziness, sleepiness and low-blood pressure outweighed its benefits.

FDA此前已经驳回该药物两次，称其潜在的副作用(包括晕眩、恶心、头昏、嗜睡和低血压)远超其疗效。